(BSPM)

Biostar Pharmaceuticals, Inc.

Close Price:
1.28

Change:
-0.03 Stock Price Decrease0.03

% Change:
-0.0229007633587786259541984733 Stock Price Decrease2.29 %

Date:
5/18/2012

52 Week:
1.21 - 4.47

Prev Close:
1.31

Open:
1.27

Volume:
29,172

90D Avg. Volume:
79,618

5/18/2012 Range:
1.25 - 1.36

Market Cap:
12,032,000

Trailing PE Ratio:
1.03

Shares Out:
9,400,000

EPS:
1.24

Yield:
0.00

Dividend:
0.00

Dividend Date:
-

Quarter End:
6/30/2012

Biostar Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Major

Website: www.biostarpharmaceuticals.com

Business Summary: Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products, and health supplement products for various diseases and conditions in the People?s Republic of China. Its primary product includes the Xin Ao Xing Oleanolic Acid Capsule, an OTC medicine for the treatment of chronic hepatitis B. The company?s products also include Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat pain, headache, and fever; and Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for the treatment of pain and other symptoms associated with menstruation. Its prescription pharmaceutical products comprise Danshen granule for the treatment of coronary heart disease, myocarditis, and angina pectoris; and Taohuasan pediatric medicine for the treatment of bronchial congestion and coughs in children. The company also manufactures hernia belt; and five health supplements. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of dedicated sales people in approximately 22 provinces. The company was founded in 1995 and is headquartered in Xianyang, the People?s Republic of China.


Shiji Avenue
Xianyang
City, 712000 China ,
P: 86 29 3368 6638

BSPM Earnings Calendar

Q1:
Dec
31
 -
Mar
30
Q2:
Mar
31
 -
Jun
30
Q3:
Jun
30
 -
Sep
29
Q4:
Sep
30
 -
Dec
30
Period Ending
 
Assets
Current Assets
Cash & Cash Equivalents
Short Term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
Long Term Assets
Property Plant & Equipment
Goodwill
Intangible Assets
Accumulated Amortization
Other Assets
Deferred Long Asset Charges
Total Assets
Liabilities
Current Liabilities
Accounts Payable
Short/Current Long Term Debt
Other Current Liabilities
Total Current Liabilities
Long Term Debt
Other Liabilities
Deferred Long Term Liability Charges
Minority Interest
Negative Goodwill
Total Liabilities
Stockholders' Equity
Misc Stock Options Warrants
Redeemable Preferred Stock
Preferred Stock
Common Stock
Retained Earnings
Treasury Stock
Capital Surplus
Other Stockholder Equity
Total Stockholder Equity
Net Tangible Assets
12/31/2009
 
 
 
$8,578
$0
$19,803
$340
$0
$30,222
$0
$4,341
$0
$11,132
$0
$1,316
$0
$47,010
 
 
$6,091
$0
$0
$6,091
$0
$0
$0
$0
$0
$6,091
 
$0
$0
$3
$23
$0
$0
$19,801
$3,543
$40,920
$29,788
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
YoY
 
 
 
1,031.7%
0.0%
69.2%
7.6%
0.0%
92.5%
0.0%
(26.8%)
0.0%
51.1%
0.0%
0.0%
0.0%
62.1%
 
 
6.4%
0.0%
0.0%
6.4%
0.0%
0.0%
0.0%
0.0%
0.0%
6.4%
 
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
89.8%
94.3%
75.8%
87.3%
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
12/31/2008
 
 
 
$758
$0
$11,701
$316
$0
$15,701
$0
$5,930
$0
$7,366
$0
$0
$0
$28,998
 
 
$5,725
$0
$0
$5,725
$0
$0
$0
$0
$0
$5,725
 
$0
$0
$0
$23
$0
$0
$10,430
$1,823
$23,273
$15,907
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
Period Ending
 
Assets
Current Assets
Cash & Cash Equivalents
Short Term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
Long Term Assets
Property Plant & Equipment
Goodwill
Intangible Assets
Accumulated Amortization
Other Assets
Deferred Long Asset Charges
Total Assets
Liabilities
Current Liabilities
Accounts Payable
Short/Current Long Term Debt
Other Current Liabilities
Total Current Liabilities
Long Term Debt
Other Liabilities
Deferred Long Term Liability Charges
Minority Interest
Negative Goodwill
Total Liabilities
Stockholders' Equity
Misc Stock Options Warrants
Redeemable Preferred Stock
Preferred Stock
Common Stock
Retained Earnings
Treasury Stock
Capital Surplus
Other Stockholder Equity
Total Stockholder Equity
Net Tangible Assets
6/30/2010
 
 
 
$9,664
$0
$25,292
$1,864
$0
$39,088
$0
$5,151
$0
$11,233
$0
$881
$0
$56,353
 
 
$6,847
$0
$0
$6,847
$0
$0
$0
$0
$0
$6,847
 
$0
$0
$1
$27
$0
$0
$20,418
$4,535
$49,506
$38,273
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
QoQ
 
 
 
396.4%
0.0%
65.3%
232.3%
0.0%
66.0%
0.0%
(6.6%)
0.0%
56.0%
0.0%
0.0%
0.0%
55.4%
 
 
49.4%
0.0%
(100.0%)
(6.1%)
0.0%
0.0%
0.0%
0.0%
0.0%
(6.1%)
 
0.0%
0.0%
0.0%
17.4%
0.0%
0.0%
95.8%
(24.2%)
70.9%
75.8%
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
3/31/2010
 
 
 
$8,642
$0
$20,837
$565
$0
$31,532
$0
$5,202
$0
$11,315
$0
$878
$0
$48,927
 
 
$5,555
$0
$0
$5,555
$0
$0
$0
$0
$0
$5,555
 
$0
$0
$1
$26
$0
$0
$19,993
$3,799
$43,372
$32,057
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
QoQ
 
 
 
1,143.5%
0.0%
50.6%
85.2%
0.0%
73.6%
0.0%
(11.0%)
0.0%
55.3%
0.0%
0.0%
0.0%
56.4%
 
 
(10.1%)
0.0%
0.0%
(10.1%)
0.0%
0.0%
0.0%
0.0%
0.0%
(10.1%)
 
0.0%
0.0%
0.0%
13.0%
0.0%
0.0%
91.7%
87.4%
72.7%
79.8%
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
Period Ending
Net Income
Operating Activities
Depreciation
Adjustments To Net Income
Changes In Accounts Receivables
Changes In Liabilities
Changes In Inventories
Changes In Other Operating Activities
Total from Operating Activities
Investing Activities
Capital Expenditures
Investments
Other Investing Activities
Total from Investing Activities
Financing Activities
Dividends Paid
Sale Purchase of Stock
Net Borrowings
Other Financing Activites
Total from Financing Activities
Effect of Exchange Rate Changes
Change in Cash and Cash Equivalents
12/31/2009
$10,498
 
$608
$1,388
($8,069)
$2,764
($24)
($1,491)
$5,674
 
($1,186)
$0
($2,342)
($3,528)
 
$0
$5,674
$0
$0
$5,674
$0
$7,819
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
YoY
56.9%
 
(5.9%)
0.0%
(12.3%)
36.4%
73.9%
47.9%
828.4%
 
(2,180.8%)
0.0%
(745.5%)
(975.6%)
 
0.0%
0.0%
100.0%
0.0%
1,139.2%
(100.0%)
611.7%
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
12/31/2008
$6,691
 
$646
$0
($7,188)
$2,026
($92)
($2,862)
($779)
 
($52)
$0
($277)
($328)
 
$0
$0
($546)
$0
($546)
$125
($1,528)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Period Ending
Net Income
Operating Activities
Depreciation
Adjustments To Net Income
Changes In Accounts Receivables
Changes In Liabilities
Changes In Inventories
Changes In Other Operating Activities
Total from Operating Activities
Investing Activities
Capital Expenditures
Investments
Other Investing Activities
Total from Investing Activities
Financing Activities
Dividends Paid
Sale Purchase of Stock
Net Borrowings
Other Financing Activites
Total from Financing Activities
Effect of Exchange Rate Changes
Change in Cash and Cash Equivalents
6/30/2010
$5,579
 
$139
$425
($4,355)
$1,375
($1,292)
($883)
$989
 
($5)
$0
$0
($5)
 
$0
$0
$0
$0
$0
$37
$1,021
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
QoQ
44.7%
 
(16.3%)
70.7%
(198.5%)
23.8%
(404.7%)
63.4%
(21.1%)
 
0.0%
0.0%
0.0%
0.0%
 
0.0%
0.0%
0.0%
0.0%
0.0%
3,800.0%
(18.5%)
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
3/31/2010
$2,263
 
$138
$154
($1,031)
($734)
($225)
$13
$580
 
($282)
$0
($265)
($547)
 
$0
$38
$0
$0
$38
($6)
$65
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
QoQ
23.7%
 
(16.9%)
0.0%
51.4%
(267.2%)
(1,975.0%)
103.4%
992.3%
 
0.0%
0.0%
0.0%
0.0%
 
0.0%
0.0%
0.0%
0.0%
0.0%
(700.0%)
201.6%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Research Development
Selling General & Administrative
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss
Income from Continuing Operations
Total Other Income/Expenses Net
Earnings Before Interest And Taxes
Interest Expense
Income Before Tax
Income Tax Expense
Minority Interest
Net Income From Continuing Ops
 
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares
12/31/2009
$53,319
$14,315
$39,004
 
$0
$23,903
$0
$0
$0
$15,101
 
($352)
$14,749
$0
$14,749
$4,251
$0
$10,498
 
 
$0
$0
$0
$0
$10,498
($2,671)
$7,827
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
YoY
57.2%
1.8%
96.5%
 
0.0%
97.7%
0.0%
0.0%
0.0%
94.6%
 
(11,833.3%)
89.9%
(100.0%)
91.0%
311.5%
0.0%
56.9%
 
 
0.0%
0.0%
0.0%
0.0%
56.9%
(82.7%)
(25.8%)
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
12/31/2008
$33,911
$14,059
$19,852
 
$0
$12,090
$0
$0
$0
$7,762
 
$3
$7,765
$41
$7,724
$1,033
$0
$6,691
 
 
$0
$0
$0
$0
$6,691
($1,462)
$5,229
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Research Development
Selling General & Administrative
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss
Income from Continuing Operations
Total Other Income/Expenses Net
Earnings Before Interest And Taxes
Interest Expense
Income Before Tax
Income Tax Expense
Minority Interest
Net Income From Continuing Ops
 
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares
9/30/2010
$20,179
$5,465
$14,714
 
$0
$9,898
$0
$0
$0
$4,822
 
$4
$4,819
$0
$4,819
$1,386
$0
$3,433
 
 
$0
$0
$0
$0
$3,433
$0
$3,433
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
QoQ
29.7%
52.4%
22.9%
 
0.0%
26.0%
0.0%
0.0%
0.0%
17.2%
 
0.0%
17.1%
0.0%
17.1%
40.3%
0.0%
9.8%
 
 
0.0%
0.0%
0.0%
0.0%
9.8%
0.0%
9.8%
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
6/30/2010
$19,396
$5,005
$14,391
 
$0
$6,858
$0
$0
$0
$7,532
 
($185)
$7,348
$0
$7,348
$1,769
$0
$5,579
 
 
$0
$0
$0
$0
$5,579
$0
$5,579
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
QoQ
46.4%
42.6%
47.8%
 
0.0%
60.6%
0.0%
0.0%
0.0%
37.8%
 
25.7%
40.9%
0.0%
40.9%
30.1%
0.0%
44.7%
 
 
0.0%
0.0%
0.0%
0.0%
44.7%
0.0%
44.7%